This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Neil Matthews - Innovator in Pharmaceutical Chemistry
Introduction
Neil Matthews is a distinguished inventor based in London, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as inhibitors for specific enzymes.
Latest Patents
One of his notable patents is for the invention of 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation, and their use as cyclooxygenase 2 (COX-2) inhibitors. This invention provides a pharmaceutical composition comprising a compound of formula (I) or a pharmaceutically acceptable salt, solvate, ester, or salt or solvate of such ester, of a compound of formula (I.
Career Highlights
Neil Matthews has been associated with Smithkline Beecham Corporation, where he has utilized his expertise to advance pharmaceutical research and development. His work has led to innovative solutions in the treatment of various medical conditions.
Collaborations
He has collaborated with notable colleagues such as Paul John Beswick and Charanjit Bountra, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Neil Matthews is a prominent figure in the realm of pharmaceutical inventions, with a focus on developing effective COX-2 inhibitors. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile